Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ACADIA Pharmaceuticals

Explore full profile

Committed to developing treatments for neurological disorders

San Diego, United StatesFounded 1993Biotech & Life Sciences
Valuation $3.63B Market cap · Aug/2026
Revenue $1.24B Latest reported FY
EBITDA $67M Latest reported FY

At a glance

Status
Listed
Founded
1993
Headquarters
San Diego, United States
Listing
IPO 2004
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News Acadia's Alzheimer's psychosis drug remlifanserin posts Phase 3-enabling Phase 2 results Sep 24, 2026

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • LD Pensions
  • BankInvest
  • DKA Capital

Series B and later8 investors entered at this stage

  • Forbion Capital Partners
  • Oxford Bioscience Partners
  • OrbiMed
  • Hambrecht & Quist Capital Management
  • Federated Hermes
  • LD Pensions
  • NEA
  • University of Vermont

Talent

Book a demo to see the people
Employees mapped 1,023 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 24 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former ACADIA Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.

Engrail TherapeuticsEst. 2019
Stephen CunninghamUnited States
Signal score68
LophoraEst. 2018
Anders Asbjørn JensenDenmark
Signal score64
Lassen TherapeuticsEst. 2018
Mark BarrettUnited States
Signal score60
OpeekaEst. 2019
KCKate Duggento CordellUnited States
Signal score53
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
13 countries with
team presence
🇺🇸 United States96%
🇨🇭 Switzerland1.4%
🇨🇦 Canada1%
🇩🇪 Germany0.3%
🇳🇱 Netherlands0.3%
Top 5 of 13 shown
Web traffic by country
34K monthly visits
across markets
🇺🇸 United States57.4%
🇦🇺 Australia6.5%
🇬🇧 United Kingdom6.2%
🇮🇳 India5.9%
🇨🇦 Canada4.7%
Top 5 markets shown

Patents

Estimated portfolio value
$43M

34 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ACADIA Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ACADIA Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles